Virtus Biotech Clinical TriaBBCETF
13F holders, Q3 2025 (September 30)12holders +1
2new positions
1sold out
$27.29avg. 13F price*
At the end of Q3 2025, 12 institutions reported holding Virtus Biotech Clinical Tria (BBC) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were Militia Capital Partners, LP ($1.5M), Susquehanna International Group, LLP ($944K) and Jane Street Group, LLC ($907K).
- Company
- Virtus Biotech Clinical Tria
- Filed as
- ETFIS SER TR I (Q3 2025)
- CUSIP
- 26923G301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.0M |
| Exits | 1 | $19K |
All 13F filers, Q2 2025 → Q3 2025: 73,031 shares bought and 12,129 shares sold, net +60,902 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Militia Capital Partners, LP | 0.68% | Add +24.1% | 53,593 | $1.5M |
| Susquehanna International Group, LLP | 0.00% | Add +211.1% | 34,571 | $944K |
| Jane Street Group, LLC | 0.00% | New | 33,227 | $907K |
| LPL Financial LLC | 0.00% | Reduce -0.3% | 12,460 | $340K |
| Morgan Stanley | 0.00% | Add +27.0% | 10,740 | $293K |
| Simplex Trading, LLC | 0.00% | New | 3,661 | $99K |
| Dynamic Wealth Strategies, LLC | 0.01% | No change | 802 | $22K |
| Osaic Holdings, Inc. | 0.00% | No change | 303 | $8K |
| UBS Group AG | 0.00% | Reduce -98.9% | 123 | $3K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 110 | $3K |
| Allworth Financial LP | 0.00% | No change | 10 | $273 |
| NewEdge Advisors, LLC | 0.00% | No change | 5 | $136 |
"% of holder's portfolio" is BBC's weight in each manager's 13F, not the share of Virtus Biotech Clinical Tria the manager owns.